Cargando…

Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines

Cardiac hepatopathy refers to acute or chronic liver damage caused by cardiac dysfunction in the absence of any other possible causative reasons of liver injury. There is a large number of evidence of the fact that cardiac hepatopathy is associated with poor clinical outcomes in patients with acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Berezin, Alexander A., Obradovic, Zeljko, Berezina, Tetiana A., Boxhammer, Elke, Lichtenauer, Michael, Berezin, Alexander E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951884/
https://www.ncbi.nlm.nih.gov/pubmed/36830074
http://dx.doi.org/10.3390/antiox12020516
_version_ 1784893490177507328
author Berezin, Alexander A.
Obradovic, Zeljko
Berezina, Tetiana A.
Boxhammer, Elke
Lichtenauer, Michael
Berezin, Alexander E.
author_facet Berezin, Alexander A.
Obradovic, Zeljko
Berezina, Tetiana A.
Boxhammer, Elke
Lichtenauer, Michael
Berezin, Alexander E.
author_sort Berezin, Alexander A.
collection PubMed
description Cardiac hepatopathy refers to acute or chronic liver damage caused by cardiac dysfunction in the absence of any other possible causative reasons of liver injury. There is a large number of evidence of the fact that cardiac hepatopathy is associated with poor clinical outcomes in patients with acute or actually decompensated heart failure (HF). However, the currently dominated pathophysiological background does not explain a role of metabolic regulative proteins secreted by hepatocytes in progression of HF, including adverse cardiac remodeling, kidney injury, skeletal muscle dysfunction, osteopenia, sarcopenia and cardiac cachexia. The aim of this narrative review was to accumulate knowledge of hepatokines (adropin; fetuin-A, selenoprotein P, fibroblast growth factor-21, and alpha-1-microglobulin) as adaptive regulators of metabolic homeostasis in patients with HF. It is suggested that hepatokines play a crucial, causative role in inter-organ interactions and mediate tissue protective effects counteracting oxidative stress, inflammation, mitochondrial dysfunction, apoptosis and necrosis. The discriminative potencies of hepatokines for HF and damage of target organs in patients with known HF is under on-going scientific discussion and requires more investigations in the future.
format Online
Article
Text
id pubmed-9951884
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99518842023-02-25 Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines Berezin, Alexander A. Obradovic, Zeljko Berezina, Tetiana A. Boxhammer, Elke Lichtenauer, Michael Berezin, Alexander E. Antioxidants (Basel) Review Cardiac hepatopathy refers to acute or chronic liver damage caused by cardiac dysfunction in the absence of any other possible causative reasons of liver injury. There is a large number of evidence of the fact that cardiac hepatopathy is associated with poor clinical outcomes in patients with acute or actually decompensated heart failure (HF). However, the currently dominated pathophysiological background does not explain a role of metabolic regulative proteins secreted by hepatocytes in progression of HF, including adverse cardiac remodeling, kidney injury, skeletal muscle dysfunction, osteopenia, sarcopenia and cardiac cachexia. The aim of this narrative review was to accumulate knowledge of hepatokines (adropin; fetuin-A, selenoprotein P, fibroblast growth factor-21, and alpha-1-microglobulin) as adaptive regulators of metabolic homeostasis in patients with HF. It is suggested that hepatokines play a crucial, causative role in inter-organ interactions and mediate tissue protective effects counteracting oxidative stress, inflammation, mitochondrial dysfunction, apoptosis and necrosis. The discriminative potencies of hepatokines for HF and damage of target organs in patients with known HF is under on-going scientific discussion and requires more investigations in the future. MDPI 2023-02-17 /pmc/articles/PMC9951884/ /pubmed/36830074 http://dx.doi.org/10.3390/antiox12020516 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Berezin, Alexander A.
Obradovic, Zeljko
Berezina, Tetiana A.
Boxhammer, Elke
Lichtenauer, Michael
Berezin, Alexander E.
Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines
title Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines
title_full Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines
title_fullStr Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines
title_full_unstemmed Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines
title_short Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines
title_sort cardiac hepatopathy: new perspectives on old problems through a prism of endogenous metabolic regulations by hepatokines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951884/
https://www.ncbi.nlm.nih.gov/pubmed/36830074
http://dx.doi.org/10.3390/antiox12020516
work_keys_str_mv AT berezinalexandera cardiachepatopathynewperspectivesonoldproblemsthroughaprismofendogenousmetabolicregulationsbyhepatokines
AT obradoviczeljko cardiachepatopathynewperspectivesonoldproblemsthroughaprismofendogenousmetabolicregulationsbyhepatokines
AT berezinatetianaa cardiachepatopathynewperspectivesonoldproblemsthroughaprismofendogenousmetabolicregulationsbyhepatokines
AT boxhammerelke cardiachepatopathynewperspectivesonoldproblemsthroughaprismofendogenousmetabolicregulationsbyhepatokines
AT lichtenauermichael cardiachepatopathynewperspectivesonoldproblemsthroughaprismofendogenousmetabolicregulationsbyhepatokines
AT berezinalexandere cardiachepatopathynewperspectivesonoldproblemsthroughaprismofendogenousmetabolicregulationsbyhepatokines